GPT-Rosalind (OpenAI) vs MiniMax M2 / M2.5
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
MiniMax M2 / M2.5
MiniMax's open-weights frontier -- first open model to match Claude Opus 4.6 on SWE-Bench at 10-20× lower cost
| Category | GPT-Rosalind (OpenAI) | MiniMax M2 / M2.5 |
|---|---|---|
| Ease of Use | 3.0 | 6.5 |
| Output Quality | 9.0 | 9.0 |
| Value | 7.0 | 9.5 |
| Features | 8.0 | 8.5 |
| Overall | 6.8 | 8.4 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | MiniMax M2 / M2.5 |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Benchmark Head-to-Head
MiniMax M2.5 (230B/10B active MoE) benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks
| Benchmark | Description | Score |
|---|---|---|
| MMLU-Pro | Harder multi-subject reasoning | 82.1% |
| GPQA Diamond | Graduate-level science questions | 76.8% |
| SWE-Bench Verified | 80.2% | |
| HumanEval | Python code generation | 91% |
| AIME 2025 | 85.3% |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick MiniMax M2 / M2.5 if...
- ✓Easier to use (6.5 vs 3)
- ✓Better value for money (9.5/10)
- ✓Has a free tier
Agentic coding and tool-use workflows on a budget. Best price-to-SWE-Bench ratio of any open-weights model in 2026.
Visit MiniMax M2 / M2.5Our Verdict
MiniMax M2 / M2.5 is the clear winner here with 8.4/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but MiniMax M2 / M2.5 outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.